Open Access
         Immunology Journals




www.biomedcentral.com
BMC Immunology is an open access, peer-reviewed journal that
                                          considers articles ...
Immunity & Ageing is an open access, peer-reviewed, online journal
www.immunityageing.com
                                ...
THE BENEFITS OF PUBLISHING IN
BIOMED CENTRAL’S JOURNALS:

OPEN ACCESS
  Access to the research published in our
  journals...
Upcoming SlideShare
Loading in …5
×

Open Access Immunology Journals

1,854
-1

Published on

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,854
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Open Access Immunology Journals

  1. 1. Open Access Immunology Journals www.biomedcentral.com
  2. 2. BMC Immunology is an open access, peer-reviewed journal that considers articles on molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system. www.biomedcentral.com/bmcimmunol BMC Immunology is covered by PubMed, MEDLINE, BIOSIS, CAS, editorial@biomedcentral.com Scopus, EMBASE, Scopus, Google Scholar and Thomson Reuters Impact Factor: 2.66 (ISI). Arthritis Research & Therapy is an international, peer-reviewed online journal publishing original research, reviews, commentaries and reports. The major focus of the journal is in mechanisms of, and translational laboratory and clinical research into localised and systemic immune-inflammatory and degenerative diseases of http://arthritis-research.com the musculoskeletal system. Phase I, II and III clinical trials are also editorial@arthritis-research.com published. Editors-in-Chief: Peter E Lipsky (USA), Arthritis Research & Therapy is covered by PubMed, PubMed Ravinder N Maini (UK) Central, Google Scholar, MEDLINE, Scopus, Thomson Reuters (ISI), Impact Factor: 4.49 CABI, CAS and EMBASE. Allergy, Asthma & Clinical Immunology, the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that aims to further the understanding and treatment of allergic and immunologic disease. www.aacijournal.com By offering a high-visibility forum for new insights and discussions, the journal provides a platform for the dissemination of allergy editorial@aacijournal.com and clinical immunology research and reviews amongst allergists, Editor-in-Chief: Richard Warrington immunologists and other physicians, healthcare workers, medical (Canada) students and the public world wide. AACI is covered by PubMed, PubMed Central, CAS, PubMed Canada, Google Scholar, EMBASE and Scopus. JOURNAL OF NEUROINFLAMMATION Journal of Neuroinflammation is an open access, peer-reviewed online journal that focuses on innate immunological responses www.jneuroinflammation.com of the central nervous system, involving microglia, astrocytes, editorial@jneuroinflammation.com cytokines, chemokines, and related molecular processes. Editors-in-Chief: Sue T Griffin (USA), Journal of Neuroinflammation is covered by PubMed, PubMed Robert E Mrak (USA) Central, Thomson Reuters (ISI), CAS, BIOSIS, EMBASE, MEDLINE, Impact Factor: 3.21 CABI, Scopus and Google Scholar. Clinical and Molecular Allergy is an open access, peer-reviewed, online journal that publishes research on human allergic and CMA immunodeficient disease (immune deficiency not related to HIV infection/AIDS). The scope of the journal encompasses all aspects of the clinical, genetic, molecular and inflammatory aspects of allergic-respiratory (Type 1 hypersensitivity) and non- www.clinicalmolecularallergy.com AIDS immunodeficiency disorders. However, studies of allergic/ allergy@etsu.edu hypersensitive aspects of HIV infection/AIDS or drug desensitization Editors-in-Chief: David S Chi (USA), protocols in AIDS are acceptable. Guha Krishnaswamy (USA) Clinical and Molecular Allergy is covered by PubMed, PubMed Unofficial Impact Factor: 3.06 Central, CAS, EMBASE, Scopus and Google Scholar. www.biomedcentral.com/submit
  3. 3. Immunity & Ageing is an open access, peer-reviewed, online journal www.immunityageing.com that considers manuscripts on all aspects of ageing examined from immunity_ageing@unipa.it an immunological point of view. Editor-in-Chief: Calogero Caruso (Italy) Immunity & Ageing is covered by PubMed, PubMed Central, CAS, Unofficial Impact Factor: 3.12 Scopus, EMBASE and Google Scholar. Immunome Research is an open access, peer-reviewed, online journal integrating cutting edge basic and clinical immunology research, genomics, proteomics, bioinformatics, and mathematical modelling with traditional laboratory research. The journal provides coverage of topics within the field of immunomics, www.immunome-research.com including immunoinformatics, applications of genomics, Susanne.heinzel@health.sa.gov.au proteomics, metabolomics, personalised medicine and diagnostics Editor-in-Chief: Nikolai Petrovsky relevant to the immune system and its diseases. A journal of the (Australia) International Immunomics Society. Immunome Research is covered by PubMed, PubMed Central, CAS, Scopus, EMBASE and Google Scholar. Journal of Immune Based Therapies and Vaccines (JIBTV) is an open access, peer-reviewed, online journal dedicated to all aspects www.jibtherapies.com of therapeutic and prophylactic applications of immunology. editor.jibtv@googlemail.com JIBTV is covered by PubMed, PubMed Central, CAS, EMBASE, Scopus Editor-in-Chief: Robert W Malone (USA) and Google Scholar. Journal of Inflammation is an open access, peer-reviewed online journal on all aspects of research into inflammation. The journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings. www.journal-inflammation.com Journal of Inflammation is affiliated with the British Inflammation editorial@journal-inflammation.com Research Association (BIRAs). Editors-in-Chief: Paul Kirkham (UK), Journal of Inflammation is covered by PubMed, PubMed Central, Dennis Taub (USA) Thomson Reuters (ISI), BIOSIS, CAS, EMBASE, Scopus and Google Unofficial Impact Factor: 1.75 Scholar Stem Cell Research & Therapy aims to be the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it will publish open access research articles http://stemcellres.com of outstanding quality. Stem Cell Research & Therapy will have a editorial@stemcellres.com special emphasis on translational, laboratory, and clinical research Editors-in-Chief: Rocky S Tuan (USA), into stem cells. Timothy O’Brien (Ireland) Stem Cell Research & Therapy is covered by Google Scholar. www.biomedcentral.com/submit
  4. 4. THE BENEFITS OF PUBLISHING IN BIOMED CENTRAL’S JOURNALS: OPEN ACCESS Access to the research published in our journals is free (not only on the journal’s website but also via PubMed Central, the National Institutes of Health’s electronic archive of full text articles, UK PubMed Central and other national archives), which means anyone with Internet access can read your research. HIGH VISIBILITY Research articles are freely available to the entire global scientific and medical communities. Average full-text downloads are 250 per article per month. INCLUDED IN PUBMED All research articles published in BioMed Central’s journals are included in PubMed, so your work can be found and cited by researchers and clinicians around the world. YOU RETAIN COPYRIGHT Global Health Gateway This means you can freely post your article on your personal or institutional homepage www.biomedcentral.com/ and e-mail it to friends and colleagues. gateways/globalhealth PUBLISHED QUICKLY Online submission and peer review makes the whole process of publishing your research CONTACT INFORMATION simple and efficient. Articles are published rapidly upon acceptance. Customer Services BioMed Central NO SPACE CONSTRAINTS Customer Services Dept Publishing online means unlimited space for Floor 6 figures, extensive data and video footage. 236 Gray’s Inn Road London, WC1X 8HL, UK GET YOUR ARTICLE PROMOTED When appropriate, articles are promoted Tel: 0800 389 8136 (UK) by e-mailing selected groups of researchers Tel: +44 (0)20 3192 2009 working in the same field or by informing Fax: +44 (0)20 3192 2010 the general and/or scientific press. Email: info@biomedcentral.com To submit your next article to a journal published by BioMed Central go to www.biomedcentral.com/submit

×